CoChat

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Open access
Aftimos, Philippe, Oliveira, Mafalda, Irrthum, Alexandre, Fumagalli, Debora, Sotiriou, Christos, Gal-Yam, Einav Nili, Robson, Mark E., Ndozeng, Justin, Di Leo, Angelo, Ciruelos, Eva M., de Azambuja, Evandro, Viale, Giuseppe, Scheepers, Elsemieke D., Curigliano, Giuseppe, Bliss, Judith M., Reis-Filho, Jorge S., Colleoni, Marco, Balic, Marija, Cardoso, Fatima, Albanell, Joan, Duhem, Caroline, Marreaud, Sandrine, Romagnoli, Dario, Rojas, Beatriz, Gombos, Andrea, Wildiers, Hans, Guerrero-Zotano, Angel, Hall, Peter, Bonetti, Andrea, Larsson, Karolina Fs, Degiorgis, Martina, Khodaverdi, Silvia, Greil, Richard, Sverrisdóttir, Ásgerdur, Paoli, Marta, Seyll, Ethel, Loibl, Sibylle, Linderholm, Barbro, Zoppoli, Gabriele, Davidson, Nancy E., Johannsson, Oskar Th, Bedard, Philippe L., Loi, Sherene, Knox, Susan, Cameron, David A., Harbeck, Nadia, Montoya, Maite Lasa, Brandão, Mariana, Vingiani, Andrea, Caballero, Carmela, Hilbers, Florentine S., Yates, Lucy R., Benelli, Matteo, Venet, David, Piccart, Martine J. · 2021 · Cancer Discovery
Cited by 179

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

AURORA aims to study the processes of relapse in metastatic breast cancer (MBC) by performing multi-omics profiling on paired primary tumors and early-course metastases. Among 381 patients (primary tumor and metastasis pairs: 252 targeted gene sequencing, 152 RNA sequencing, 67 single nucleotide polymorphism arrays), we found a driver role for GATA1 and MEN1 somatic mutations. Metastases were enriched in ESR1, PTEN, CDH1, PIK3CA, and RB1 mutations; MDM4 and MYC amplifications; and ARID1A deletions. An increase in clonality was observed in driver genes such as ERBB2 and RB1. Intrinsic subtype switching occurred in 36% of cases. Luminal A/B to HER2-enriched switching was associated with TP53 and/or PIK3CA mutations. Metastases had lower immune score and increased immune-permissive cells. High tumor mutational burden correlated to shorter time to relapse in HR+/HER2− cancers. ESCAT tier I/II alterations were detected in 51% of patients and matched therapy was used in 7%. Integration of multi-omics analyses in clinical practice could affect treatment strategies in MBC. Significance: The AURORA program, through the genomic and transcriptomic analyses of matched primary and metastatic samples from 381 patients with breast cancer, coupled with prospectively collected clinical data, identified genomic alterations enriched in metastases and prognostic biomarkers. ESCAT tier I/II alterations were detected in more than half of the patients. This article is highlighted in the In This Issue feature, p. 2659

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-1647

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 179

Metadata

Authors
Aftimos, P., Oliveira, M., Irrthum, A., Fumagalli, D., Sotiriou, C., Gal-Yam, E. N., Robson, M. E., Ndozeng, J., Di Leo, A., Ciruelos, E. M., de Azambuja, E., Viale, G., Scheepers, E. D., Curigliano, G., Bliss, J. M., Reis-Filho, J. S., Colleoni, M., Balic, M., Cardoso, F., Albanell, J., Duhem, C., Marreaud, S., Romagnoli, D., Rojas, B., Gombos, A., Wildiers, H., Guerrero-Zotano, A., Hall, P., Bonetti, A., Larsson, K. F., Degiorgis, M., Khodaverdi, S., Greil, R., Sverrisdóttir, Á., Paoli, M., Seyll, E., Loibl, S., Linderholm, B., Zoppoli, G., Davidson, N. E., Johannsson, O. T., Bedard, P. L., Loi, S., Knox, S., Cameron, D. A., Harbeck, N., Montoya, M. L., Brandão, M., Vingiani, A., Caballero, C., Hilbers, F. S., Yates, L. R., Benelli, M., Venet, D., & Piccart, M. J.
Venue
Cancer Discovery
Published
2021-06-28
Volume
11
Issue
11
Pages
2796-2811
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3176308859
Cited by
179
References
15
FWCI
10.48
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. https://app.cochat.ai/papers/10.1158/2159-8290.cd-20-1647
The paper
Aftimos, P., Oliveira, M., Irrthum, A., Fumagalli, D., Sotiriou, C., Gal-Yam, E. N., Robson, M. E., Ndozeng, J., Di Leo, A., Ciruelos, E. M., de Azambuja, E., Viale, G., Scheepers, E. D., Curigliano, G., Bliss, J. M., Reis-Filho, J. S., Colleoni, M., Balic, M., Cardoso, F., . . . Piccart, M. J. (2021). Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-20-1647

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.